These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9894765)

  • 21. [Genetic predisposition to breast cancer: a review in April 1998].
    Stoppa-Lyonnet D
    Contracept Fertil Sex; 1999; 27(7-8):517-20. PubMed ID: 10495568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators.
    Gayther SA; de Foy KA; Harrington P; Pharoah P; Dunsmuir WD; Edwards SM; Gillett C; Ardern-Jones A; Dearnaley DP; Easton DF; Ford D; Shearer RJ; Kirby RS; Dowe AL; Kelly J; Stratton MR; Ponder BA; Barnes D; Eeles RA
    Cancer Res; 2000 Aug; 60(16):4513-8. PubMed ID: 10969800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BRCA1 susceptibility markers and postmenopausal breast cancer: the Iowa Women's Health Study.
    Thompson JA; Chen PL; King RA; Rich SS; Oetting WS; Armstrong C; Folsom AR; Sellers TA
    Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):507-11. PubMed ID: 10815696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic counseling in hereditary breast/ovarian cancer in Israel: psychosocial impact and retention of genetic information.
    DiCastro M; Frydman M; Friedman I; Shiri-Sverdlov R; Papa MZ; Goldman B; Friedman E
    Am J Med Genet; 2002 Aug; 111(2):147-51. PubMed ID: 12210341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer.
    Steinmann D; Bremer M; Rades D; Skawran B; Siebrands C; Karstens JH; Dörk T
    Br J Cancer; 2001 Sep; 85(6):850-8. PubMed ID: 11556836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families.
    Vahteristo P; Eerola H; Tamminen A; Blomqvist C; Nevanlinna H
    Br J Cancer; 2001 Mar; 84(5):704-8. PubMed ID: 11237395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral contraceptive use and BRCA penetrance: a case-only study.
    Pasanisi P; Hédelin G; Berrino J; Chang-Claude J; Hermann S; Steel M; Haites N; Hart J; Peled R; Gafà L; Leggio L; Traina A; Amodio R; Primic-Zakelj M; Zadnik V; Veidebaum T; Tekkel M; Berrino F
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2107-13. PubMed ID: 19549808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Women's decisions regarding management of breast cancer risk.
    MacDonald DJ
    Medsurg Nurs; 2002 Aug; 11(4):183-6. PubMed ID: 12219430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer.
    Kuschel B; Lux MP; Goecke TO; Beckmann MW
    Eur J Cancer Prev; 2000 Jun; 9(3):139-50. PubMed ID: 10954253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychological issues in genetic testing for breast cancer.
    Carter CL; Hailey BJ
    Women Health; 1999; 28(4):73-91. PubMed ID: 10378346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 'A low risk is still a risk': exploring women's attitudes towards genetic testing for breast cancer susceptibility in order to target disease prevention.
    Henneman L; Timmermans DR; Bouwman CM; Cornel MC; Meijers-Heijboer H
    Public Health Genomics; 2011; 14(4-5):238-47. PubMed ID: 20090298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic predisposition testing for breast cancer.
    Audeh MW
    Cancer J Sci Am; 1997; 3(4):254-5. PubMed ID: 9263632
    [No Abstract]   [Full Text] [Related]  

  • 33. "Decoding" informed consent. Insights from women regarding breast cancer susceptibility testing.
    Geller G; Strauss M; Bernhardt BA; Holtzman NA
    Hastings Cent Rep; 1997; 27(2):28-33. PubMed ID: 9131350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interest and attitudes of patients, cancer physicians, medical students and cancer researchers towards a spectrum of genetic tests relevant to breast cancer patients.
    Ngoi N; Lee SC; Hartman M; Khin LW; Wong A
    Breast; 2013 Feb; 22(1):47-52. PubMed ID: 22560561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast cancer susceptibility testing: Part 1.
    Gilbert F
    Genet Test; 1997; 1(2):73. PubMed ID: 10464629
    [No Abstract]   [Full Text] [Related]  

  • 36. Knowledge, attitudes and behavior of physicians regarding predictive genetic tests for breast and colorectal cancer.
    Marzuillo C; De Vito C; Boccia S; D'Addario M; D'Andrea E; Santini P; Boccia A; Villari P
    Prev Med; 2013 Nov; 57(5):477-82. PubMed ID: 23827720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Women's interest in genetic testing for breast cancer susceptibility may be based on unrealistic expectations.
    Press NA; Yasui Y; Reynolds S; Durfy SJ; Burke W
    Am J Med Genet; 2001 Mar; 99(2):99-110. PubMed ID: 11241466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Saudi women's interest in breast cancer gene testing: possible influence of awareness, perceived risk and socio-demographic factors.
    Amin TT; Al-Wadaani HA; Al-Quaimi MM; Aldairi NA; Alkhateeb JM; Al-Jaafari AA
    Asian Pac J Cancer Prev; 2012; 13(8):3879-87. PubMed ID: 23098487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The genetics of sporadic and inherited breast cancer.
    Kamm BL
    Radiol Technol; 1998; 69(4):299-311; quiz 312-4. PubMed ID: 9549762
    [No Abstract]   [Full Text] [Related]  

  • 40. Informed consent documents for BRCA1 and BRCA2 screening: how large is the readability gap?
    Gribble JN
    Patient Educ Couns; 1999 Nov; 38(3):175-83. PubMed ID: 10865683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.